NY stem cell research nears dangerous line
By Jesse Reynolds,
Newsday
| 01. 23. 2009
Stem cell research may soon make headlines again. The restrictions on federal funding imposed by former President George W. Bush are expected to be lifted. But here in New York, a different type of stem cell controversy is brewing.
Since 2007, the state has managed a large stem cell research funding program of its own, second only to that of California. While it has quietly been issuing millions of dollars in grants for a wide range of work, the program is considering crossing an unprecedented - and dangerous - ethical line.
Most of the debates around stem cell research have focused on the use of embryos left over in fertility clinics. Hopeful parents undergoing assisted reproduction often end up with more embryos than they need, and these could be used in medical research. Bush's policy limited federal funding for this line of work; President Barack Obama is expected to lift that restriction very soon.
The issue in New York is different. If stem cells could be derived from embryos made using cloning techniques, they would have all the genes of...
Related Articles
By Paula Siverino Bavio, BioNews | 03.16.2026
State flag of Peru via Wikimedia Commons licensed under CC by SA 2.0
A recent surrogacy case in Peru had a good outcome for one family, but does not provide wider certainty for families, surrogates or clinicians, writes Dr Paula...
By Antonia O'Flaherty, ABC News Australia | 03.04.2026
Fertility giant Monash IVF has agreed to pay financial settlements to families involved in two major bungles that saw two women transferred the wrong embryo.
In February 2025 the company became aware that one of its Brisbane clinic's patients had...
By Dr. Marcin Śmietana, Progress Educational Trust (PET) | 03.02.2026
When a family created through surrogacy abroad returns to their home country after the birth of the child, the genetic parent(s) are usually recognised as legal parents by default. However, any parent without a genetic link to the child needs...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...
.jpg){kind=link}